NCT00574496 2023-09-28
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
The Lymphoma Academic Research Organisation
Alliance for Clinical Trials in Oncology
University of Cologne
Newcastle-upon-Tyne Hospitals NHS Trust
Memorial Sloan Kettering Cancer Center
Ospedale Santa Croce-Carle Cuneo
University College, London
Children's Oncology Group